Acetic Acid → HCID 69028266, compound
Reaction equation
Cl.[NH2:2][C:3]1[CH:10]=[C:9]([CH2:11][N:12]2[CH2:17][CH2:16][CH:15]([CH2:18][C:19]3[NH:23][C:22]4[CH:24]=[C:25]([Cl:28])[CH:26]=[CH:27][C:21]=4[N:20]=3)[CH2:14][C:13]2=[O:29])[CH:8]=[CH:7][C:4]=1[C:5]#[N:6].[CH2:30]([N:32](CC)CC)C.C(O)(=O)C.N1C=CC=NN=1>C(O)C>[NH2:6][C:5]1[C:4]2[C:3](=[CH:10][C:9]([CH2:11][N:12]3[CH2:17][CH2:16][CH:15]([CH2:18][C:19]4[NH:23][C:22]5[CH:24]=[C:25]([Cl:28])[CH:26]=[CH:27][C:21]=5[N:20]=4)[CH2:14][C:13]3=[O:29])=[CH:8][CH:7]=2)[N:2]=[CH:30][N:32]=1Participants
Reactant 4
Product 1
Reagents, catalysts & solvents 1
Procedure
To a solution of 2-Amino-4-[4-(6-chloro-1H-benzoimidazol-2-ylmethyl)-2-oxo-piperidin-1-ylmethyl]-benzonitrile hydrochloric acid salt (143 mg, 0.308 mmol), EXAMPLE 814, Part E, in 2 mL of ethanol is added triethylamine (0.05 mL, 0.366 mmol), glacial acetic acid (0.02 mL, 0.366 mmol) and triazine (15 mg, 0.183 mmol). The resulting mixture is refluxed overnight. The volatile solvents are removed on the rotovap, and the residue is purified by reverse phase HPLC (0-50% Acetonitrile/H2O). The desired product (110 mg, 55% yield) is isolated as a white powder with a melting point of 128-132 ° C. C22H21ClN6O MS m/z: 421, 423. Anal. calcd. for C22H21ClN6O: C, 48.12; H,3.57; N, 12.95. Found: C, 45.79; H, 3.68; N, 11.94. H NMR (CD3OD) δ: 8.67 (s, 1H); 8.31 (d, 1H, J=4.0 Hz); 7.83-7.55 (m, 5H); 4.93-4.73 (m, 2H); 3.48-3.42 (m, 2H); 3.31-3.21 (m, 2H); 2.71-2.58 (m, 2H); 2.43-2.33 (m, 1H); 2.07-2.01 (m, 1H); 1.82-1.69 (m, 1H).
Workup
- temperatureThe resulting mixture is refluxed overnight
- customThe volatile solvents are removed on the rotovap
- customthe residue is purified by reverse phase HPLC (0-50% Acetonitrile/H2O)
Sources & evidence
- ORD record
- ord-b60a8e0b5808412bb33d67f5f832183d
- Source dataset
- uspto-grants-2009_11
- Patent number
- US07612075B2
Reaction notes
Loading…